https://www.pharmanow.live/latest-news/tarsus-pharmaceuticals-acquires-alkeus-pharmaceuticals-alk-001-stargardt 2026-09-04T22:18:32+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Tarsus Acquires Alkeus, Adds Phase 3 Stargardt Drug Tarsus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f48f05bc-2c0d-47e1-bb45-c5c3bd586fe6/072421b7-6f12-4d89-abaa-c38a174b481d.png https://www.pharmanow.live/latest-news/teva-gains-investment-grade-status-sp-upgrade-bbb-minus 2026-09-04T22:24:39+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Teva Gains Investment-Grade Status from All Three Major Rating Agencies After S&P Upgrade https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f48f05bc-2c0d-47e1-bb45-c5c3bd586fe6/04fb8233-b54b-4595-8fc0-4c7ea07ee32f.png https://www.pharmanow.live/latest-news/fda-cber-biologics-regulatory-resource-hub-bla-compliance 2026-09-04T22:25:29+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 FDA CBER Consolidates Biologics Regulatory Resource Hub for BLA and Compliance Teams FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f48f05bc-2c0d-47e1-bb45-c5c3bd586fe6/51764277-0d78-4ca0-a2af-53bf97bcc92c.png https://www.pharmanow.live/latest-news/peptides-complex-generics-symposium-2026-returns-to-mumbai 2026-09-04T18:24:43+05:30 Pharma Now en 2026-09-04T18:24:38+05:30 Peptides & Complex Generics Symposium 2026 Returns to Mumbai Peptides & Complex Generics Symposium 2026, PCG 2026, peptide therapeutics, complex generics, https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/image(1)20260904181315.png https://www.pharmanow.live/latest-news/astrazeneca-hutchmed-tagrisso-orpathys-phase-iii-nsclc-china 2026-09-04T22:26:44+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 AstraZeneca, HUTCHMED Win Phase III NSCLC Trial AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/f92207c6-f6a6-451c-92d2-c414d59fb52d.png https://www.pharmanow.live/latest-news/weave-bio-takeda-ai-regulatory-platform-14-drug-programs 2026-09-04T22:27:48+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Weave Bio and Takeda Deploy AI Regulatory Platform Across 14 Drug Programs Weave https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/d4af46b9-588b-43a5-a3d4-a2db603820c8.png https://www.pharmanow.live/latest-news/abbvie-etentamig-phase-3-multiple-myeloma-60-percent-progression-risk-reduction 2026-09-04T22:29:25+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 AbbVie Achieves 60% Progression Risk Reduction for Etentamig in Phase 3 Multiple Myeloma Trial https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/7db887e0-abe6-4935-90d8-8c74af0ef460.png https://www.pharmanow.live/latest-news/cipla-qilu-pembrolizumab-biosimilar-us-deal 2026-09-04T22:24:05+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Cipla Signs Qilu Deal to Launch Pembrolizumab Biosimilar in U.S. Cipla https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/f502ce66-5ad3-449c-b64c-f8b2fb9bcccd.png https://www.pharmanow.live/latest-news/ema-resolves-visudyne-shortage-new-eu-manufacturing-sites-verteporfin 2026-09-04T22:31:48+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 EMA Resolves Visudyne Shortage After Registering New EU Manufacturing Sites for Verteporfin EMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/6a545ce4-c1a6-4cdd-9844-d5791a5e6d81.png https://www.pharmanow.live/latest-news/ema-prac-injectable-iron-safety-review-hypophosphataemia-bone-risk-2026 2026-09-04T22:28:23+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 EMA PRAC Launches Safety Review of Injectable Iron Medicines Over Hypophosphataemia and Bone Risk EMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f431ec85-2d3d-40c5-8154-818e52dda4df/0210ac02-8bcb-4749-91bb-9a568f81345d.png https://www.pharmanow.live/latest-news/cms-dermavon-nmpa-approval-lumirix-atopic-dermatitis 2026-09-04T22:30:28+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 CMS's Dermavon Gains NMPA Approval for Lumirix in Pediatric Atopic Dermatitis CMS https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4caaf01a-103e-4eea-97df-2c2ed7979271/88ca0d2d-3d69-4671-a0cc-e429847cec20.png https://www.pharmanow.live/latest-news/agilent-launches-icp-ms-gc-systems-digital-lab-platform-india 2026-09-04T10:46:30+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Agilent Launches ICP-MS, GC Systems and Digital Lab Platform Agilent https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/70e0237d-c086-43bf-8960-5e8af717b7be.png https://www.pharmanow.live/latest-news/cohance-lifesciences-18-million-nj-bio-aruka-bio-adc-manufacturing 2026-09-04T10:46:30+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Cohance Lifesciences Secures $18M Stake in NJ & Aruka Bio Cohance Lifesciences https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/528c1cec-f162-4b87-92e4-11f2a017005e.png https://www.pharmanow.live/latest-news/rpg-life-sciences-acquires-raghava-life-sciences-api-business 2026-09-04T10:46:30+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 RPG Life Sciences Acquires Raghava Life Sciences API Business RPG Life Sciences https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/2542da71-85c2-4487-9fcd-37cbb2880110.png https://www.pharmanow.live/latest-news/american-regent-epinephrine-recall-particulate-sterility-2026 2026-09-04T10:46:29+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 American Regent Recalls Three Epinephrine Lots Over Cracked Vials American Regent https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/fa50f240-e3fa-4a9d-9e36-2b2a13e6ee98.png https://www.pharmanow.live/latest-news/cipla-invagen-qilu-keytruda-biosimilar-us-deal 2026-09-04T10:46:33+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Cipla InvaGen Signs Biosimilar Deal with Qilu for US Market Cipla https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/23279db7-e1c8-41de-abf4-2f3901c83fc3/b0b615a9-a8e7-4fe5-8c61-21a1df9d210f.png https://www.pharmanow.live/latest-news/axcelead-fda-nams-road-map-seminar-ind-submission-strategy 2026-09-04T10:47:55+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Axcelead Releases FDA NAMs Road Map Seminar on IND Strategy Axcelead https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://axcelead-us.com/wp-content/uploads/2026/09/20260904-Webinar-TIM-1.png https://www.pharmanow.live/latest-news/pendopharm-cda-amc-conditional-reimbursement-yorvipath-chronic-hypoparathyroidism 2026-09-04T10:51:05+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 Pendopharm Secures AMC Reimbursement Nod for Yorvipath Pendopharm https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/54fc8afb-c164-4d78-93f3-dff346091b3b/49f0e6be-51c7-46e6-a0c3-f7cc62dd8387.png https://www.pharmanow.live/latest-news/cber-regulatory-framework-allergenic-products-biologics 2026-09-04T10:56:01+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 CBER Maintains Framework for Three Allergenic Products CBER https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/54fc8afb-c164-4d78-93f3-dff346091b3b/4f2d8a80-67b8-4482-b441-0eda2b02799a.png https://www.pharmanow.live/latest-news/fda-approves-zanvastro-first-treatment-alexander-disease 2026-09-04T10:57:04+05:30 Pharma Now en 2026-09-04T00:00:00+05:30 FDA Approves Zanvastro as First Treatment for Alexander Disease FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/54fc8afb-c164-4d78-93f3-dff346091b3b/c79a4398-47ea-4071-b04a-2dad7c6a2d76.png https://www.pharmanow.live/latest-news/fda-estradiol-transdermal-patch-supply-shortfall-2026 2026-09-04T17:22:25+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 FDA Works With Six Manufacturers to Ease Estradiol Patch Shortage FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda_estradiol_transdermal_patch_supply_shortfall20260904172118.webp https://www.pharmanow.live/latest-news/fda-ema-joint-workshop-botanical-drug-development-2026 2026-09-04T18:01:12+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 FDA and EMA Join Forces on Botanical Drug Development FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda_ema_joint_workshop_botanical_drug_development_202620260904180101.webp https://www.pharmanow.live/latest-news/fda-2026-2027-influenza-vaccine-strain-recommendations 2026-09-04T18:06:18+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 FDA Finalizes 2026–2027 Flu Vaccine Strain Selection FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/influenza_virus_flu_vaccine_vial_fda_2026_2027_strain_recommendations20260904180545.webp https://www.pharmanow.live/latest-news/abbvie-acquires-apogee-therapeutics-10-9b-half-life-extended-antibody-pipeline 2026-09-04T18:14:42+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 AbbVie Acquires Apogee Therapeutics for Half-Life Extended Antibody Pipeline AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie_logo_acquires_apogee_therapeutics_10_9b_antibody_pipeline20260904181428.webp https://www.pharmanow.live/latest-news/fibrobiologics-secures-us-patent-3d-spheroid-fibroblast-wound-healing 2026-09-04T18:20:17+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 FibroBiologics Secures U.S. Patent for 3D Spheroid Fibroblast Wound Healing Therapy https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fibrobiologics_logo_us_patent_3d_spheroid_fibroblast_wound_healing20260904181822.webp https://www.pharmanow.live/latest-news/abbvie-phase-3-cervino-trial-etentamig-rrmm-results-2026 2026-09-04T18:43:46+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 AbbVie’s Etentamig Meets Dual Endpoints in Phase 3 Myeloma Trial AbbVie’ https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie_headquarters_building_phase_3_cervino_trial_etentamig_rrmm_202620260904184329.webp https://www.pharmanow.live/latest-news/cellipont-bioservices-texas-facility-six-ind-submissions-2026 2026-09-04T18:49:27+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 Cellipont Texas Facility Supports Six 2026 IND Programs Cellipont https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cellipont_bioservices_facility_texas_six_ind_submissions_202620260904184742.webp https://www.pharmanow.live/latest-news/eledon-pharmaceuticals-islet-cell-ind-tegoprubart-transplant-programs-2026 2026-09-03T22:11:32+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 Eledon Submits Islet Cell IND for Tegoprubart Eledon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/79280130-d192-4773-a188-a686cd3ad144/c17d9b38-7ba9-4958-88dc-9a7972fffe29.png https://www.pharmanow.live/latest-news/wuxi-apptec-extrahepatic-oligonucleotide-delivery-cdmo-manufacturing 2026-09-03T22:18:07+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 WuXi AppTec Explores CDMO Shifts in Oligonucleotide Delivery WuXi https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/79280130-d192-4773-a188-a686cd3ad144/627ae22e-2a03-4056-add4-39143fe7b7e2.png https://www.pharmanow.live/latest-news/inventiva-completes-last-patient-visit-nativ3-phase-3-lanifibranor-mash 2026-09-03T10:27:15+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 Inventiva Completes Last Patient Visit in NATiV3 Phase 3 Trial Inventiva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2c2915a6-9bb2-4de2-b3b9-3c9a9a35504a/0acf9cd9-7c60-49f6-85f5-0b8a5a383226.png https://www.pharmanow.live/latest-news/pfizer-biontech-covid-19-eua-revoked-comirnaty-bla-manufacturing-controls 2026-09-03T10:23:06+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 Pfizer COVID-19 Vaccine EUA Revoked; Comirnaty BLA Takes Effect Pfizer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2c2915a6-9bb2-4de2-b3b9-3c9a9a35504a/f7b07337-fddf-4a91-9a74-8d72ddb874f8.png https://www.pharmanow.live/latest-news/moderna-spikevax-eua-revocation-bla-approval-fda-2025 2026-09-03T10:26:17+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 Moderna Loses EUA Status as Spikevax Gains Full FDA Approval Moderna https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2c2915a6-9bb2-4de2-b3b9-3c9a9a35504a/cea1b0eb-5453-4fe7-8f20-ac7e2f97cb5d.png https://www.pharmanow.live/latest-news/fda-standard-safety-tables-figures-nda-bla-review-framework 2026-09-03T10:20:48+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 FDA Issues Safety Tables & Figures Framework for NDA/BLA Reviews FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8282a666-d316-4b32-9efd-294f94386135/5e161d7f-3683-4c6e-b944-25da97352b57.png https://www.pharmanow.live/latest-news/fda-gcp-enforcement-foreign-clinical-trial-sites-inspection-risk 2026-09-03T10:20:54+05:30 Pharma Now en 2026-09-03T00:00:00+05:30 FDA Signals GCP Shift as Foreign Trial Sites Face Inspections FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8282a666-d316-4b32-9efd-294f94386135/64ad42f1-0149-434e-a0c6-f839cc3a7aee.png